TrialCardiovascular diabetology2025

Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes.

Paola Giustina Simeone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.